DOCSLIB.ORG

Detection of Rare Deletion Mutation in the Alpha-Globin Gene Locus Establishes a Diagnosis of Hb H Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Detection of Rare Deletion Mutation in the Alpha-Globin Gene Locus Establishes a Diagnosis of Hb H Disease REPRINTED FROM FEBRUARY 2018 PATHOLOGY ◆ LABORATORY MEDICINE ◆ LABORATORY MANAGEMENT Detection of rare deletion mutation in the alpha-globin gene locus establishes a diagnosis of Hb H disease CAP TODAY and the Association for nosis, and treatment. The following report Molecular Pathology have teamed up to comes from Quest Diagnostics. If you bring molecular case reports to CAP would like to submit a case report, please TODAY readers. AMP members write case report send an email to the AMP at [email protected]. the reports using clinical cases from their own practices that For more information about the AMP and all previously show molecular testing’s important role in diagnosis, prog- published case reports, visit www.amp.org. Neng Chen, PhD, DABMGG Patients with Hb H disease are confirm a diagnosis of Hb H disease Cathi Rubin Franklin, MS, LCGC, DABMGG often diagnosed after being seen for and provide information for genetic Franklin Quan, PhD, DABMGG microcytic anemia or other indica- counseling. The alpha-globin gene locus (Fig. 1A) tions, such as infection, hepatospleno- Patient case. A 50-year-old Afri- contains two alpha-globin genes: megaly, cholelithiasis, or severe ane- can-American male was evaluated HBA1 and HBA2. An upstream reg- mia during pregnancy. For patients by his primary care physician be- ulatory region, known as HS-40, is with low MCV, Heinz bodies after cause of anemia. Several years prior, essential for alpha-globin gene ex- brilliant cresyl blue staining of blood the patient had gastrointestinal pression.1,2 The loss or inactivation of smears, or Hb H and/or Hb Barts by bleeding and was diagnosed with one or two alpha-globin genes is not high-performance liquid chromatog- colon cancer. He was anemic and clinically significant while the loss or raphy or gel electrophoresis, the dif- transfused at that time as part of his inactivation of all four alpha-globin ferential diagnosis should include Hb treatment. His primary physician genes results in a lethal condition H disease, hemolytic anemia, and ordered blood smears and iron stud- known as hemoglobin (Hb) Barts alpha-thalassemia X-linked intellec- ies to investigate the cause of his hydrops fetalis syndrome, the most tual disability (ATRX) syndrome. anemia. The blood smears revealed severe form of alpha-thalassemia. Molecular genetic testing is used to microcytosis and the presence of The loss or inactivation of three al- pha-globin genes results in a form of A. HS-40 Pseudo HBA2 HBA1 alpha-thalassemia known as hemo- globin H (Hb H) disease. Hb H disease has a variable phe- notype. Hb H disease caused by deletions in the alpha-globin gene HS-40 Pseudo -alpha3.7 del B. Alpha-globin locus locus is associated with moderate with -alpha3.7 del anemia, microcytosis, and hypochro- mia. In contrast, nondeletional Hb H Pseudo -alpha3.7 del Alpha-globin locus disease, caused by a point mutation with HS-40 del plus -alpha3.7 del or small insertion/deletion in one of Fig.Figure 1. 1. Structure Structure of the of alpha the- globinalpha-globin gene locus. A gene. Normal locus. arrangement A. Normalof HBA1, HBA2 arrangementand HS-40. Each of alpha HBA1,-globin geneHBA2, locus and contains HS-40. two alpha Each-globin genes, the alpha-globin genes, is associated alpha-globinHBA1 and HBA2. gene HS-40 is locus the upstream contains regulatory two region alpha-globin required for alpha genes,-globin HBA1 gene expression. and HBA2. The alpha HS-40-globin isgene the locus upstream also contains regulatory two non-functional pseudo-genes. B. Genotype for the patient. One chromosome has the –alpha3.7 deletion; the other chromosome has the –alpha3.7 deletion and a HS-40 deletion. with a more severe anemia, and pa- region required for alpha-globin gene expression. The alpha-globin gene locus also contains two non-functional tients are likely to be transfusion pseudogenes. B. Genotype for the patient. One chromosome has the -alpha3.7 deletion; the other chromosome dependent. has the -alpha3.7 deletion and an HS-40 deletion. 2 | CAP TODAY target cells, indicating microcytic rule out alpha-thalassemia as a cause to the nature of the methodology anemia. Iron studies indicated that of this patient’s anemia, molecular used, the precise size and break- all tested parameters were within the testing for mutations in the alpha- points of this deletion could not be normal reference ranges (Table 1). globin locus was performed. determined. However, the data indi- Iron deficiency was ruled out as a The most common mutations cate that the deletion extends at least cause of the patient’s anemia. The causing alpha-thalassemia are large 11-kb upstream of the HS-40 region hemoccult test was positive at the deletions. Moreover, seven common but not into the downstream pseu- time of his visit to the specialist. deletions, -alpha3.7, -alpha4.2, --SEA, dogene region (Fig. 1B). The causes of anemia include se- --MED, --FIL, --THAI, and --20.5,6 The test results indicate that the vere iron deficiency, thalassemia, and account for approximately 85 percent patient has two alpha-globin fusion chronic diseases (e.g. chronic infec- of all alpha-thalassemia mutations.7 genes that should be functional. tion or inflammatory processes).3 Testing for these common deletions However, the HS-40 regulatory re- Anemia may also be idiopathic. The was performed using a multiplex gion is deleted on one chromosome. hematologist ordered a hemoglobin- gap-PCR assay.6 This testing indi- Since the HS-40 regulatory region is opathy evaluation (CBC and hemo- cated that the patient is homozygous required for the expression of the globin HPLC) to investigate the pos- for the -alpha3.7 deletion. The -al- alpha-globin genes on the same chro- sibility of thalassemia as the cause of pha3.7 deletion generates a func- mosome,1,2 the fusion gene on the this patient’s anemia. The RBC indi- tional alpha-globin fusion gene that chromosome with the HS-40 deletion ces (Table 2) clearly showed that this consists of exon 1 of the HBA2 gene is expected to be nonfunctional. Con- patient was severely anemic. and exons 2 and 3 of the HBA1 gene. sequently, this patient has only one The hemoglobin HPLC (Table 3) Therefore, the test results indicated functional alpha-globin gene, which was normal, with the exception of the that the patient has two functional is consistent with a diagnosis of Hb Hb A2 level, which was slightly be- alpha-globin genes, a result that was H disease. Since deletions in the al- low the lower limit of the normal inconsistent with his severe anemia. pha-globin gene locus are the cause range. However, unstable Hb vari- To confirm that the patient is ho- of this patient’s Hb H disease, he is ants, such as Hb H, Hb Barts, or Hb mozygous for the -alpha3.7 deletion expected to have the milder form of Constant Spring (Hb CS), are not al- (genotype -alpha3.7/-alpha3.7) and Hb H disease.4 As a result, it would ways detected by hemoglobin HPLC not heterozygous for the -alpha3.7 not be surprising that his anemia was or gel electrophoresis. As a result, to deletion and a rare, two alpha-globin undiagnosed until he presented with gene deletion (genotype GI bleeding and colon cancer. Unfor- Table 1. Iron studies for the patient -alpha3.7/large dele- tunately, we do not have information tion), alpha-globin gene on the time course of his anemia. Parameters Case Normal reference range dosage (i.e. copy num- Nonetheless, the RBC indices in- Ferritin (ng/mL) 203 20–380 ber) was determined us- dicated this patient has anemia that Iron (mcg/dL) 61 50–180 ing a semiquantitative is more severe than expected for an TIBC (mcg/dL) 264 250–425 fluorescent PCR assay.8,9 individual with the deletional form % saturation 23 15–60 This assay measures the of Hb H disease (Table 2). The GI relative dosage of am- bleeding this patient experienced Table 2. Red blood cell indices for the patient plification products de- could cause iron deficiency, which Indices Case Normal Hb H disease rived from the HS-40 would increase the severity of his reference range reference range region, nonfunctional anemia. However, adult patients Hbg (g/dL) 8.9 14.9–16.9 8.7–10.34 pseudogenes, and re- with Hb H disease can have iron MCV (fL) 52.7 83.99–94.01 57–654 gions spanning the overload.4 Because this patient’s iron MCH (pg) 15.7 29.0–32.8 17.2–19.64 HBA2 and HBA1 genes indices were in the normal range 5 RDW (%) 32.9 11.0–15.0 21.2–34.7 (Fig. 1A). This assay (Table 1), iron overload from Hb H confirmed that the pa- disease could be compensating for Table 3. Hemoglobin analysis for the patient tient is homozygous for the iron deficiency caused by GI Hb type Case Normal Hb H disease the -alpha3.7 deletion. bleeding. As a result, it is likely that reference range reference range Unexpectedly, this as- both GI bleeding and Hb H disease Hb A (%) 97.3 96–98 60–90 say also revealed the have contributed to the severity of Hb A (%) 1.7 2–3 <2.0 2 presence of a deletion this patient’s microcytic anemia. Hb F (%) <1 <1 <1 that removes the HS-40 Continued monitoring would be Hb H (%) 0 0 0.8–40 regulatory region on necessary to determine whether this Hb Barts (%) 0 0 2–5 one chromosome. Due individual’s anemia is less severe if CAP TODAY | 3 the GI bleeding resolves.
Load more

Recommended publications
  • Identification and Characterization of a Novel 43-Bp Deletion Mutation of The
    Liu et al. BMC Medical Genetics (2018) 19:61 https://doi.org/10.1186/s12881-018-0567-z CASE REPORT Open Access Identification and characterization of a novel 43-bp deletion mutation of the ATP7B gene in a Chinese patient with Wilson’s disease: a case report Gang Liu†, Dingyuan Ma†, Jian Cheng, Jingjing Zhang, Chunyu Luo, Yun Sun, Ping Hu, Yuguo Wang, Tao Jiang* and Zhengfeng Xu* Abstract Background: Wilson’s disease (WD) is an autosomal recessive disorder characterized by copper accumulation. ATP7B gene mutations lead to ATP7B protein dysfunction, which in turn causes Wilson’s disease. Case presentation: We describe a male case of Wilson’s disease diagnosed at 10 years after routine biochemical test that showed low serum ceruloplasmin levels and Kayser–Fleischer rings in both corneas. Analysis of the ATP7B gene revealed compound heterozygous mutations in the proband, including the reported c.3517G > A mutation and a novel c.532_574del mutation. The c.532_574del mutation covered a 43-bp region in exon 2, and resulted in a frameshift mutation (p.Leu178PhefsX10). By base sequence analysis, two microhomologies (TCTCA) were observed on both deletion breakpoints in the ATP7B gene. Meanwhile, the presence of some sequence motifs associated with DNA breakage near the deletion region promoted DNA strand break. Conclusions: By comparison, a replication-based mechanism named fork stalling and template switching/ microhomology-mediated break-induced replication (FoSTeS/MMBIR) was used to explain the formation of this novel deletion mutation. Keywords: Wilson’s disease, ATP7B, Novel mutation, FoSTeS/MMBIR Background ATP7B protein dysfunction, which in turn causes accumu- Wilson’s disease (WD, OMIM #277900), an autosomal lation of copper in the liver, brain, kidneys and corneas, recessive disorder characterized by abnormal copper ac- with a wide range of clinical symptoms, including hepatic cumulation and related toxicities, is caused by mutations disorders, neuronal degeneration of the brain, and Kayser- in the ATP7B gene (OMIM *606882) [1].
    [Show full text]
  • Nf1 Gene Deletion
    NF1 GENE DELETION NF1 GENE DELETION This resource is for families who have a deletion of the NF1 gene causing neurofi bromatosis type 1 (NF1). This is also referred to as NF1 microdeletion. WHAT ARE CHROMOSOMES, DELETION GENES AND MUTATIONS? Chromosomes are the packages of our genetic information. Within each cell of the body are 46 chromosomes arranged in 23 pairs. One chromosome in each pair is inherited from the Source: U.S. National Library of Medicine mother and the other from the father. The pairs are numbered WHAT IS AN NF1 MICRODELETION? by size. The number 1 chromosome When the entire NF1 gene is missing, it is referred pair is the largest and the number 22 is to as NF1 gene deletion or NF1 microdeletion. the smallest. The last pair of chromosomes Approximately 5% of individuals with a diagnosis (sex chromosomes) help to determine whether of NF1 have a deletion that includes the entire NF1 an individual is a male or a female. Genes are gene. Other than the NF1 gene, there are usually small areas along the chromosomes, and are other nearby genes that are also missing. the body’s blueprints or instructions. We have approximately 20,000 genes that control how we WHAT DOES IT MEAN TO HAVE AN NF1 grow and develop and what we look like. Each MICRODELETION? gene can be thought of as a sentence made up of In addition to the NF1 gene, individuals with NF1 four letters (A, T, C and G). Mutations (also called microdeletion typically have other genes in the pathogenic variants), are changes in a gene’s region of chromosome 17 deleted.
    [Show full text]
  • Status of the P53, P16, RB1, and HER-2 Genes and Chromosomes 3
    367 ORIGINAL ARTICLE J Clin Pathol: first published as 10.1136/jcp.2004.021154 on 24 March 2005. Downloaded from Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters M Gallucci, F Guadagni, R Marzano, C Leonardo, R Merola, S Sentinelli, E M Ruggeri, R Cantiani, I Sperduti, F de la Iglesia Lopez, A M Cianciulli ............................................................................................................................... J Clin Pathol 2005;58:367–371. doi: 10.1136/jcp.2004.021154 Aims: To evaluate a panel of well known genetic alterations for frequency of changes in bladder cancer that could be considered genomic instability determinants or adjunctive prognostic predictors. Methods: Fluorescence in situ hybridisation analysis was performed to evaluate chromosomes 3, 7, 9, and 17 and the 9p21 (p16), 17p13.1 (p53), 13q14 (RB1), and 17q11.2 (HER-2) chromosomal loci in 48 See end of article for muscle invasive bladder cancer specimens and the adjacent normal mucosa. authors’ affiliations Results: There were significant differences between the frequency of chromosome 7 monosomy/polysomy ....................... and 17 monosomy in the two groups (tumours and adjacent mucosa) (p = 0.004, p = 0.037, and Correspondence to: p = 0.015, respectively). There were no differences in the frequency of gene deletions between tumours Dr A M Cianciulli, Clinical and the adjacent mucosa. 17q11.2 amplification was found in 14.5% of tumours examined, but not in the Pathology, Regina Elena non-malignant epithelium. Chromosome 3, 7, and 17 monosomy and the RB1 heterozygous deletion were Cancer Institute, IFO, Via Elio Chianesi, 53, 00144 significantly associated with stage T3–4 (p = 0.03, p = 0.04, p = 0.04, and p = 0.03, respectively).
    [Show full text]
  • The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: a Review
    Journal of Clinical Medicine Review The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review Felix Scholkmann 1,2,*, Tanja Restin 2, Marco Ferrari 3 and Valentina Quaresima 3 1 Biomedical Optics Research Laboratory, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland 2 Newborn Research Zurich, Department of Neonatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; [email protected] 3 Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] (M.F.); [email protected] (V.Q.) * Correspondence: [email protected]; Tel.: +41-4-4255-9326 Abstract: Following the outbreak of a novel coronavirus (SARS-CoV-2) associated with pneumonia in China (Corona Virus Disease 2019, COVID-19) at the end of 2019, the world is currently facing a global pandemic of infections with SARS-CoV-2 and cases of COVID-19. Since severely ill patients often show elevated methemoglobin (MetHb) and carboxyhemoglobin (COHb) concentrations in their blood as a marker of disease severity, we aimed to summarize the currently available published study results (case reports and cross-sectional studies) on MetHb and COHb concentrations in the blood of COVID-19 patients. To this end, a systematic literature research was performed. For the case of MetHb, seven publications were identified (five case reports and two cross-sectional studies), and for the case of COHb, three studies were found (two cross-sectional studies and one case report). The findings reported in the publications show that an increase in MetHb and COHb can happen in COVID-19 patients, especially in critically ill ones, and that MetHb and COHb can increase to dangerously high levels during the course of the disease in some patients.
    [Show full text]
  • Koolen-De Vries Syndrome: Clinical Report of an Adult and Literature Review
    Case Report Cytogenet Genome Res 2016;150:40–45 Accepted: July 25, 2016 DOI: 10.1159/000452724 by M. Schmid Published online: November 17, 2016 Koolen-de Vries Syndrome: Clinical Report of an Adult and Literature Review Claudia Ciaccio Chiara Dordoni Marco Ritelli Marina Colombi Division of Biology and Genetics, Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia , Italy Key Words Koolen-de Vries syndrome (KdS, also known as 17q21.31 · Deletion · Joint hypermobility · KANSL1 17q21.31 microdeletion syndrome, OMIM #610443) is a rare genetic disorder (prevalence 1/16,000) characterized by typical facial dysmorphisms, cardiac and renal defects, Abstract developmental delay, and intellectual disability of vari- Koolen-de Vries syndrome (KdS) is a rare genetic condition able level [Tan et al., 2009]. The disorder was initially de- characterized by typical facial dysmorphisms, cardiac and re- scribed as a form of mental retardation caused by a 440– nal defects, skeletal anomalies, developmental delay, and in- 680-kb deletion in the 17q21.31 region, typically encom- tellectual disability of variable level. It is caused by a 440– passing 5 genes: CRHR1 (OMIM 122561), MAPT 680-kb deletion in the 17q21.31 region, encompassing (OMIM 157140), IMP5 (OMIM 608284), STH (OMIM CRHR1 , MAPT , IMP5 , STH , and KANSL1 , or by an intragenic 607067), and KANSL1 (OMIM 612452)* [Koolen et al., KANSL1 mutation. The majority of the patients reported are 2006]. Recently,* it has been shown* that haploinsufficien- pediatric or young adults, and long-term studies able to de- cy* of KANSL1 by itself, due to single* nucleotide variants fine the prognosis of the disease are lacking.
    [Show full text]
  • Trisomy 5P Inverted Duplication & Deletion of 5Pftnwdraft3
    Trisomy 5p: Inverted duplication and deletion of 5p rarechromo.org Inverted duplication with deletion of 5p Inverted duplication with deletion of 5p, known as inv dup del 5p, is a very rare genetic condition in which there is an extra copy of part of the genetic material (DNA) that makes up the body’s 46 chromosomes, and a missing copy of another part. Like most other chromosome disorders, this usually affects development, and sometimes health and behaviour as well. It is likely that both the extra and missing parts of chromosome 5p have an effect, but a lot depends on their position and size. The precise effects of gaining material from a chromosome vary depending on how large the duplication is, how many genes it contains and what those genes do. The same applies to deletions. The effects may not be limited to the genes within the duplicated or deleted piece of chromosome because these genes may interact with other genes on the same chromosome or other chromosomes. Chromosomes usually come in pairs, and we inherit one chromosome from each parent. Of the 46 chromosomes, two are a pair of sex chromosomes: two Xs for a girl and an X and a Y for a boy. The remaining 44 chromosomes are grouped into 22 pairs and are numbered 1 to 22, approximately from largest to smallest. Each chromosome has a short (p) arm (from petit, the French for small) and a long (q) arm. The diagram below shows the short arm. Chromosome 5 Short (p) arm Bands Base pairs 0Mb 5Mb 10Mb 15Mb 20Mb 25Mb 30Mb 35Mb 40Mb 45Mb 48.4Mb Long (q) arm 2 People have 2 copies of chromosome 5 in most of their body cells.
    [Show full text]
  • Structure and Function of Leghemoglobins*
    203 Structure and function of leghemoglobins* by M. BECANA**, J.F. MORAN, I. ITURBE-ORMAETXE, Y. GOGORCENA and P.R. ESCUREDO Departamento de Nutrición Vegetal, Estación Experimental de Aula Dei (C.S.I.C.), Apartado 202, 50080 Zaragoza Received: 31-10-1994 Key words: Free radicals, Iron, Leghemoglobins, Nitrogen fixation, Oxygen, Plant senescence, Root nodules. Abbreviation: Lb, leghemoglobin. ABSTRACT Becana, M., Moran, J.F., Iturbe-Ormaetxe, I., Gogorcena, Y. and Escuredo, P.R. 1995. Structure and function of leghemoglobins. An. Estac. Exp. Aula Dei (Zaragoza) 21(3): 203-208. Leghemoglobin (Lb) is a myoglobin-like protein of about 16 kDa, which occurs in legume root nodules at very high concentra - tions. Usually the heme moiety is synthesized by the bacteroids but mitochondria may provide also heme for Lb when bacteria are defective in heme production or perhaps when Lb is produced in uninfected cells of nodules. Lb plays an essential role in the nitro - gen fixation process, by providing oxygen to the bacteroids at a low, but constant, concentration, which allows for simultaneous bac - teroid respiration and nitrogenase activity. Lb must be in the reduced, ferrous state to carry oxygen. Several factors within the nodu - les are conducive for Lb oxidation to its ferric, inactive form. During these inactivation reactions free radicals are generated. Howe - ver, healthy nodules contain around 80% of ferrous Lb and 20% of oxyferrous Lb, but not ferric Lb, which indicates that mechanisms exist in the nodules to maintain Lb reduced; these are the enzyme ferric Lb reductase and free flavins. Lb degradation is a largely unk - nown process, but several intermediates with modified hemes,presumably by oxidative attack,have been encountered, including modi - fied Lbam, choleglobin, and biliverdin.
    [Show full text]
  • Early Fetal Presentation of Koolen-De Vries: Case Report with Literature Review
    European Journal of Medical Genetics xxx (2017) 1e5 Contents lists available at ScienceDirect European Journal of Medical Genetics journal homepage: http://www.elsevier.com/locate/ejmg Early fetal presentation of Koolen-de Vries: Case report with literature review abstract Keywords: Koolen-de Vries syndrome (MIM#610443) is a rare microdeletion syndrome involving the 17q21.31 Koolen-de Vries syndrome region, which was first described by Koolen in 2006. Clinical and behavioral characteristics have been 17q21.31 deletion extensively reported from more than 100 postnatal cases including infants, children and young adults. Prenatal array-CGH The syndrome is highly clinically heterogeneous, but the main features associate characteristic cranio- Neuropathology facial dysmorphism, heart defects, limb, skeletal, genito-urinary anomalies, along with intellectual Cytogenetics Mega corpus callosum disability with early childhood epilepsy and behavioral disturbances. Central nervous system malfor- mations usually consist in hydrocephalus and thin corpus callosum. We report herein an early fetal case with an apparently isolated abnormal corpus callosum diagnosed by ultrasonography, for which a medical termination of the pregnancy was achieved at 22 weeks of gestation. Postmortem examination displayed facial dysmorphism consisting of hypertelorism, short philtrum and flat and broad nose, cleft palate and left duplex ureter. Neuropathological examination revealed a mega corpus callosum that has never been reported so far in this syndrome. Array-CGH performed
    [Show full text]
  • The Deletion Stocks of Common Wheat
    The Deletion Stocks of Common Wheat T. R. Endo and B. S. Gill Chromosomal breaks occurred in the progeny of a common wheat (Tritlcum aes- tlvum L. em Thell; 2n = 6x = 42, genome formula AABBDD) cultivar Chinese Spring with a monosomic addition of an alien chromosome from Aegllops cyllndrlca Host (2n = 4x = 28, CCDD) or A. trlunclalls L. (2n = 4x = 28, UUCC) or a chromosomal segment from A. spettoldes Tausch (2n = 2x = 14, SS). We identified 436 deletions by C-banding. The deletion chromosomes were transmitted stably to the offspring. We selected deletion homozygotes in the progeny of the deletion heterozygotes and established homozygous lines for about 80% of the deletions. We failed to establish homozygous lines for most of the deletions In the short arm of chromo- some 2A and for all deletions in the short arm of chromosome 4B, because plants homozygous for these deletions were sterile. We could not obtain any homozygotes for larger deletions In the long arms of chromosomes 4A, 5A, 5B, and 5D. The deletion stocks showed variations in morphological, physiological, and biochemi- cal traits, depending on the size of their chromosomal deficiency, and are powerful tools for physical mapping of wheat chromosomes. The aneuploid stocks developed in a com- and a chromosome fragment from A. spel- mon wheat cultivar Chinese Spring are a toides were found recently to induce chro- powerful tool for genetic and breeding mosome mutations in Chinese Spring in studies of wheat (Sears 1954, 1966; Sears the same manner as the A. cylindrica chro- and Sears 1978). These stocks are im- mosome (Endo, unpublished data).
    [Show full text]
  • A Rare and Unusual Case of Trisomy 10P with Terminal 14Q Deletion: a Multidisciplinary Approach
    Open Access Case Report DOI: 10.7759/cureus.15459 A Rare and Unusual Case of Trisomy 10p with Terminal 14q Deletion: A Multidisciplinary Approach Chanan Goyal 1, 2 , Vivek Goyal 3 , Waqar M. Naqvi 1 1. Community Physiotherapy, Datta Meghe Institute of Medical Sciences, Wardha, IND 2. Paediatric Physiotherapy, Government Physiotherapy College, Raipur, IND 3. Anaesthesiology, Shri Balaji Institute of Medical Science, Raipur, IND Corresponding author: Chanan Goyal, [email protected] Abstract Trisomy 10p is a rare entity to be diagnosed and so is terminal 14q deletion. The total number of trisomy 10p cases reported to date is estimated to be in double digits. The number of terminal 14q deletion cases that have been reported in the literature is even lesser than that of trisomy 10p. Simultaneous occurrence of these genetic aberrations is, therefore, extremely rare. Herein, we document a case of a 14-month-old female diagnosed with trisomy 10p and terminal 14q deletion, who presented with an inability to sit without support and had difficulty in holding her neck. She had no means of independent indoor mobility, which was further limiting her development by exploration. Clinical features included hypotonia, developmental delay, extraneous movements of the head and tongue, intellectual impairment, and facial dysmorphism. She could maintain tripod sitting for less than a minute. Physiotherapy intervention was based on principles of neurodevelopmental treatment and sensory integration. After nine months of physiotherapy intervention, her total gross motor function measure (GMFM) score improved from 11% to 40%. The functional gains were maintained with a home exercise program, after almost one year of discontinuation of institution-based physiotherapy.
    [Show full text]
  • Chain of Human Neutrophil Cytochrome B CHARLES A
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 3319-3323, May 1988 Biochemistry Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b CHARLES A. PARKOS*, MARY C. DINAUERt, LESLIE E. WALKER*, RODGER A. ALLEN*, ALGIRDAS J. JESAITIS*, AND STUART H. ORKINtt *Department of Immunology, Research Institute of the Scripps Clinic, La Jolla, CA 92037; tDivision of Hematology-Oncology, Children's Hospital, and Dana-Farber Cancer Institute, Department of Pediatrics, Harvard Medical School, Boston, MA 02115; and tHoward Hughes Medical Institute, Children's Hospital, Boston, MA 02115 Communicated by Harvey F. Lodish, January 14, 1988 ABSTRACT Cytochrome b comprising 91-kDa and 22- Cytochrome b purified from neutrophil membranes ap- kDa subunits is a critical component of the membrane-bound pears to be a heterodimer of a glycosylated 91-kDa heavy oxidase of phagocytes that generates superoxide. This impor- chain and a nonglycosylated 22-kDa light chain (10-12). The tant microbicidal system is impaired in inherited disorders 91-kDa subunit is encoded by a gene designated CGD, known as chronic granulomatous disease (CGD). Previously we residing at chromosomal position Xp2l, which originally was determined the sequence of the larger subunit from the cDNA identified on the basis of genetic linkage without reference to of the CGD gene, the X chromosome locus affected in "X- a specific protein product (8). Antisera generated to either a linked" CGD. To complete the primary structure of the synthetic peptide predicted from the cDNA or to a fusion cytochrome b and to assess expression of the smaller subunit, protein produced in E.
    [Show full text]
  • Microduplications of 22Q11.2 Are Frequently Inherited and Are Associated with Variable Phenotypes Zhishuo Ou, MD1, Jonathan S
    April 2008 ⅐ Vol. 10 ⅐ No. 4 article Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes Zhishuo Ou, MD1, Jonathan S. Berg, MD, PhD1, Hagith Yonath, MD1, Victoria B. Enciso, MS2, David T. Miller, MD, PhD3, Jonathan Picker, MD3, Tiffanee Lenzi, MD, PhD4, Catherine E. Keegan, MD, PhD4, Vernon R. Sutton, MD1,5, John Belmont, MD, PhD1,5, A. Craig Chinault, PhD1, James R. Lupski, MD, PhD1,5,6, Sau Wai Cheung, PhD, MBA1, Elizabeth Roeder, MD2, and Ankita Patel, PhD1 Purpose: Genomic rearrangements of chromosome 22q11.2, including the microdeletion associated with Di- George/velocardiofacial syndrome, are mediated by nonallelic homologous recombination between region-specific low-copy repeats. To date, only a small number of patients with 22q11.2 microduplication have been identified. Methods: We report the identification by array-comparative genomic hybridization of 14 individuals from eight families who harbor microduplications within the 22q11.2 region. Results: We have now observed a variety of microduplications, including the typical common ϳ3-Mb microduplication, ϳ1.5-Mb nested duplication, and smaller microduplications within and distal to the DiGeorge/velocardiofacial syndrome region, consistent with nonallelic homologous recombination using distinct low-copy repeats in the 22q11.2 DiGeorge/velocardiofacial syndrome region. These microduplications likely represent the predicted reciprocal rearrangements to the microde- letions characterized in the 22q11.2 region. The phenotypes seen in these individuals are generally mild and highly variable; familial transmission is frequently observed. Conclusions: These findings highlight the unbiased ability of array-comparative genomic hybridization to identify genomic imbalances and further define the molecular etiology and clinical phenotypes seen in microduplication 22q11.2 syndrome.
    [Show full text]